research article

Phase 2a study of copanlisib, a novel phosphatidylinositol-3-kinase (PI3K) inhibitor, in patients with relapsed/refractory, indolent or aggressive lymphoma

Authors
Publication date
1 January 2014
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    The University of Manchester - Institutional Repository

    redirect
    oaioai:pure.atira.dk:openaire_cri...
    Last time updated on 09/10/2025